Medi-Caps Limited (BOM:523144)
India · Delayed Price · Currency is INR 24.56
-1.38 (-5.32%)
At close: Aug 20, 2026
Medi-Caps Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 124.36 | 123.96 | 254.77 | 273.45 | 493.71 | 698.71 |
Other Revenue | 1.11 | 0.53 | - | - | - | - |
| 125.48 | 124.49 | 254.77 | 273.45 | 493.71 | 698.71 | |
Revenue Growth | -42.89% | -51.14% | -6.83% | -44.61% | -29.34% | 18.99% |
Cost of Revenue | 69.37 | 75.3 | 106.52 | 95.18 | 229.05 | 301.11 |
Gross Profit | 56.11 | 49.19 | 148.26 | 178.28 | 264.66 | 397.61 |
Selling, General & Admin | 86.47 | 87.75 | 81.71 | 78.41 | 84.93 | 92.22 |
Other Operating Expenses | 48.3 | 55.55 | 84.82 | 100.21 | 129.11 | 205.22 |
Operating Expenses | 153 | 161.37 | 183.71 | 195.49 | 231.47 | 315.57 |
Operating Income | -96.89 | -112.18 | -35.46 | -17.21 | 33.19 | 82.04 |
Interest Expense | - | -0.13 | -0.25 | - | -0.02 | -0.1 |
Interest & Investment Income | - | - | 6.61 | 0.04 | 0.03 | 5.3 |
Currency Exchange Gain (Loss) | - | - | 1.69 | 2.79 | 8.88 | 8.59 |
Other Non Operating Income (Expenses) | 79.25 | 82.08 | 1.2 | -0 | - | 0 |
EBT Excluding Unusual Items | -17.64 | -30.23 | -26.21 | -14.38 | 42.08 | 95.83 |
Gain (Loss) on Sale of Investments | - | - | 17.8 | 1.92 | 7.13 | 4.27 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.47 |
Pretax Income | -17.64 | -30.23 | -8.41 | -12.46 | 49.21 | 100.58 |
Income Tax Expense | 0.14 | 0.14 | -2.7 | 9.95 | 30.54 | 0.14 |
Earnings From Continuing Operations | -17.79 | -30.38 | -5.71 | -22.41 | 18.66 | 100.43 |
Earnings From Discontinued Operations | - | - | - | - | -1.11 | 0.37 |
Net Income | -17.79 | -30.38 | -5.71 | -22.41 | 17.56 | 100.81 |
Net Income to Common | -17.79 | -30.38 | -5.71 | -22.41 | 17.56 | 100.81 |
Net Income Growth | - | - | - | - | -82.58% | -9.42% |
Shares Outstanding (Basic) | 12 | 12 | 12 | 12 | 12 | 12 |
Shares Outstanding (Diluted) | 12 | 12 | 12 | 12 | 12 | 12 |
Shares Change | 0.08% | -0.17% | - | - | - | - |
EPS (Basic) | -1.43 | -2.44 | -0.46 | -1.80 | 1.41 | 8.08 |
EPS (Diluted) | -1.43 | -2.44 | -0.46 | -1.80 | 1.41 | 8.08 |
EPS Growth | - | - | - | - | -82.58% | -9.47% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -78.69 | 47.43 | 65.93 | -72.44 | 42.28 |
Free Cash Flow Per Share | - | -6.32 | 3.80 | 5.29 | -5.81 | 3.39 |
Gross Margin | 44.72% | 39.51% | 58.19% | 65.20% | 53.61% | 56.91% |
Operating Margin | -77.22% | -90.12% | -13.92% | -6.29% | 6.72% | 11.74% |
Profit Margin | -14.17% | -24.40% | -2.24% | -8.20% | 3.56% | 14.43% |
Free Cash Flow Margin | - | -63.21% | 18.62% | 24.11% | -14.67% | 6.05% |
EBITDA | -78.58 | -94.1 | -18.28 | -0.35 | 51.3 | 101.07 |
EBITDA Margin | -62.63% | -75.59% | -7.17% | -0.13% | 10.39% | 14.46% |
D&A For EBITDA | 18.31 | 18.08 | 17.18 | 16.87 | 18.11 | 19.03 |
EBIT | -96.89 | -112.18 | -35.46 | -17.21 | 33.19 | 82.04 |
EBIT Margin | -77.22% | -90.12% | -13.92% | -6.29% | 6.72% | 11.74% |
Effective Tax Rate | - | - | - | - | 62.07% | 0.14% |
Revenue as Reported | 204.72 | 206.56 | 282.07 | 278.2 | 509.74 | 717.85 |
Advertising Expenses | - | - | 5.88 | 7.72 | 6.42 | 13.86 |